1,646
Views
13
CrossRef citations to date
0
Altmetric
Research Papers

Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: A randomized open-label study

, , , , , , & show all
Pages 435-442 | Received 04 Aug 2014, Accepted 12 Oct 2014, Published online: 31 Mar 2015

References

  • WHO Expert Consultation on Rabies. Second report. World Health Organ Tech Rep Ser 2013; 982:1-139, back cover; PMID:24069724
  • Yin W, Dong J, Tu C, Edwards J, Guo F, Zhou H, Yu H, Vong S. Challenges and needs for China to eliminate rabies. Infect Dis Poverty 2013; 2:23; PMID:24088366; http://dx.doi.org/10.1186/2049-9957-2-23
  • National Health and Family Planning Commission. Chinese notificable disease surveillance monthly report. http://www.moh.gov.cn/zhuzhan/yqxx/201304/b540269c8e5141e6bb2d00ca539bb9f7.shtml
  • Zhang L, Wilson DP. Trends in notifiable infectious diseases in China: implications for surveillance and population health policy. PLoS ONE 2012; 7:e31076; PMID:22359565; http://dx.doi.org/10.1371/journal.pone.0031076
  • Yin CP, Zhou H, Wu H, Shen XX, Wang LH, Yin WW, Wang SM, Tang Q. Epidemiological analysis of rabies in 2010, China. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2011; 25:434-6; PMID:22734228
  • Si H, Guo ZM, Hao YT, Liu YG, Zhang DM, Rao SQ, Lu JH. Rabies trend in China (1990–2007) and post-exposure prophylaxis in the Guangdong province. BMC Infect Dis 2008; 8:113; PMID:18717989
  • Hu R, Tang Q, Tang J, Fooks AR. Rabies in China: an update. Vector Borne Zoonotic Dis 2009; 9:1-12; PMID:18803503; http://dx.doi.org/10.1089/vbz.2008.0046
  • Hemachudha T, Wacharapluesadee S, Mitrabhakdi E, Wilde H, Morimoto K, Lewis RA. Pathophysiology of human paralytic rabies. J Neurovirol 2005; 11:93-100; PMID:15804967
  • Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, Lett S, Levis R, Meltzer MI, Schaffner W, et al. Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals. Vaccine 2009; 27:7141-8; PMID:19925944; http://dx.doi.org/10.1016/j.vaccine.2009.09.029
  • Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, Lett SM, Levis R, Meltzer MI, Schaffner W, et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 2010; 59:1-9.
  • Liu H, Huang G, Tang Q, Li J, Cao S, Fu C, Cao Q, Liu B, Pan H, Wang M. The immunogenicity and safety of vaccination with purified Vero cell rabies vaccine (PVRV) in China under a 2-1-1 regimen. Hum Vaccin 2011; 7:220-4; PMID:21311216
  • Scheiermann N, Baer J, Hilfenhaus J, Marcus I, Zoulek G. Reactogenicity and immunogenicity of the newly developed purified chick embryo cell (PCEC)-rabies vaccine in man. Zentralbl Bakteriol Mikrobiol Hyg A 1987; 265:439-50; PMID:2445127
  • Quiambao BP, Dimaano EM, Ambas C, Davis R, Banzhoff A, Malerczyk C. Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals. Vaccine 2005; 23:1709-14; PMID:15705476; http://dx.doi.org/10.1016/j.vaccine.2004.09.027
  • Dobardzic A, Izurieta H, Woo EJ, Iskander J, Shadomy S, Rupprecht C, Ball R, Braun MM. Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997-2005. Vaccine 2007; 25:4244-51; PMID:17382435
  • Briggs DJ, Banzhoff A, Nicolay U, Sirikwin S, Dumavibhat B, Tongswas S, Wasi C. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Bull World Health Organ 2000; 78:693-8; PMID:10859864
  • Sampath G, Parikh S, Sangram P, Briggs DJ. Rabies post-exposure prophylaxis in malnourished children exposed to suspect rabid animals. Vaccine 2005; 23:1102-5; PMID:15629352
  • Ambrozaitis A, Laiskonis A, Balciuniene L, Banzhoff A, Malerczyk C. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen. Vaccine 2006; 24:4116-21; PMID:16545510
  • Madhusudana SN, Anand NP, Shamsundar R. Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals. Int J Infect Dis 2002; 6:210-4; PMID:12718837; http://dx.doi.org/10.1016/S1201-9712(02)90113-X
  • Hu Q, Liu MQ, Zhu ZG, Zhu ZR, Lu S. Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China. Hum Vaccin Immunother 2014; 10:1645-9; PMID:24632727; http://dx.doi.org/10.4161/hv.28420
  • Malerczyk C, Briggs DJ, Dreesen DW, Banzhoff A. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine. J Travel Med 2007; 14:63-4; PMID:17241256
  • World Health Organization, WHO expert consultation on rabies. First report, WHO Tech Rep Ser 931, Geneva, WHO. 2005.
  • Ministry of Health, People's Republic of China. Situation of rabies prevention and control in China. http://www.moh.gov.cn, 2009.
  • Ma J, Wang H, Li J, Xie Y, Liu Z, Zhao Y, Malerczyck C. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb Regimen (2-1-1) sompared with the Essen Regimen in Chinese adults. Human Vaccines and Immunotherapeutics 2014; 10:2805-12.
  • Eng TR, Fishbein DB, Talamante HE, Hall DB, Chavez GF, Dobbins JG, Muro FJ, Bustos JL, de los Angeles Ricardy M, Munguia A, et al. Urban epizootic of rabies in Mexico: epidemiology and impact of animal bite injuries. Bull World Health Organ 1993; 71:615-24; PMID:8261565
  • Coleman PG, Fevre EM, Cleaveland S. Estimating the public health impact of rabies. Emerg Infect Dis 2004; 10:140-2; PMID:15078611
  • Leder K, Weller PF, Wilson ME. Travel vaccines and elderly persons: review of vaccines available in the United States. Clin Infect Dis 2001; 33:1553-66; PMID:11588700
  • Weinberger B, Herndler-Brandstetter D, Schwanninger A, Weiskopf D, Grubeck-Loebenstein B. Biology of immune responses to vaccines in elderly persons. Clin Infect Dis 2008; 46:1078-84; PMID:18444828; http://dx.doi.org/10.1086/529197
  • Dorrington MG, Bowdish DM. Immunosenescence and novel vaccination strategies for the elderly. Front Immunol 2013; 4:171; PMID:23825474
  • Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, Meltzer MI, Dhankhar P, Vaidya SA, Jenkins SR, et al. Human rabies prevention–United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2008; 57:1-28; PMID:18496505
  • WHO Publication. Rabies vaccines: WHO position paper–recommendations. Vaccine 2010; 28:7140-2; PMID:20831913
  • Zalan E, Wilson C, Pukitis D. A microtest for the quantitation of rabies virus neutralizing antibodies. J Biol Stand 1979; 7:213-20; PMID:387798
  • WHO expert committee on rabies. Guide for post-exposure treatment. 8th report. WHO tecnical report 824. Geneva, Switzerland: World Health Organization, 1992.
  • Song M, Tang Q, Wang DM, Mo ZJ, Guo SH, Li H, Tao XY, Rupprecht CE, Feng ZJ, Liang GD. Epidemiological investigations of human rabies in China. BMC Infect Dis 2009; 9:210; PMID:20025742
  • Wang CL, Zhang XW, Yu YX. Study on the compliance and economic cost of rabies vaccination. Zhongguo Yi Miao He Mian Yi 2010; 16:254-7; PMID:20726270

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.